Physician profile
Evan D Gross
NPI 1881646602
$784.63
in general payments reported to CMS, 2019-2025
13 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.63 · 2021: $142 · 2022: $238 · 2023: $156 · 2024: $94.04 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $196.71 | 2022-2025 | Indigo System |
| Endologix LLC | $119.36 | 2021 | |
| Mallinckrodt Hospital Products INC. | $77.99 | 2022-2024 | Acthar |
| Abiomed | $77.62 | 2023 | Impella |
| Otsuka America Pharmaceutical, INC. | $64.16 | 2022-2023 | Jynarque |
| Novartis Pharmaceuticals Corporation | $60.36 | 2024 | |
| Baxter Healthcare | $34.43 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $32.45 | 2019-2022 | |
| Nxstage Medical, INC. | $28.19 | 2023 | Nxstage System One |
| Aurinia Pharma U.S., INC. | $24.78 | 2022 | |
| Akebia Therapeutics INC | $23.16 | 2025 | Vafseo |
| Opko Pharmaceuticals, LLC | $22.76 | 2022 | |
| Daiichi Sankyo INC. | $22.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Gross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.